back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-02-24 09:45 Tx date 2023-02-19 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Anderson-Helbling, Lisa
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$29,786
+7,265 vol $4.10 each |
112,265 | |
| Filed 2023-02-23 17:15 Tx date 2022-12-13 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Anderson-Helbling, Lisa
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
105,000 | ||
| Filed 2023-02-23 17:13 Tx date 2022-12-13 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Anderson-Helbling, Lisa
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,000 | ||
| Filed 2022-01-17 10:00 Tx date 2022-01-13 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Anderson-Helbling, Lisa
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$124,500
+15,000 vol $8.30 each |
105,000 | |
| Filed 2021-01-08 10:19 Tx date 2020-11-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Anderson-Helbling, Lisa
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-360,000 vol |
90,000 | |
| Filed 2021-01-08 10:18 Tx date 2020-11-23 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Anderson-Helbling, Lisa
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-8,000 vol |
2,000 | |
| Filed 2020-09-02 14:53 Tx date 2020-09-01 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Anderson-Helbling, Lisa
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$255,000
+150,000 vol $1.70 each |
450,000 | |
| Filed 2019-12-20 11:52 Tx date 2019-12-19 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Anderson-Helbling, Lisa
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,055
+5,000 vol $0.411 each |
10,000 | |
| Filed 2019-11-13 14:51 Tx date 2019-11-13 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Anderson-Helbling, Lisa
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,289
+5,000 vol $0.4579 each |
5,000 | |
| Filed 2019-11-13 14:49 Tx date 2019-01-07 |
$IPA
ImmunoPrecise Antibodies Ltd. |
Anderson-Helbling, Lisa
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-15 Tx date 2019-01-14 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Anderson-Helbling, Lisa
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
$300,000
+300,000 vol $1.00 each |
300,000 | |
| Filed 2019-01-15 Tx date 2019-01-07 |
$IPA
ImmunoPrecise Antibodies Ltd. (formerly "Tanqueray Exploration Ltd.") |
Anderson-Helbling, Lisa
5 - Senior Officer of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|